Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections. [PDF]
Antimicrob Agents Chemother, 2023 Negatu DA +4 more
europepmc +1 more source
2016 Pipeline Report HIV and TB, Executive Summary [PDF]
, 2016 HIV and TB: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in ...
Mark Harrington
core
Selection of Multi-Drug Targets against Drug-Resistant <i>Mycobacterium tuberculosis</i> XDR1219 Using the Hyperbolic Mapping of the Protein Interaction Network. [PDF]
Int J Mol Sci, 2023 Zahra NUA +3 more
europepmc +1 more source
ANTI-TUBERCULAR ACTIVITY OF EDTA AND HOUSEHOLD CHEMICALS AGAINST MYCOBACTERIUM SMEGMATIS, A SURROGATE FOR MULTI-DRUG RESISTANT TUBERCULOSIS [PDF]
, 2015 Drug discovery efforts are increasingly being directed at re-purposing old drugs for use in treatment of multidrug resistant tuberculosis (MDRTB) which continues to pose serious health challenges worldwide.
Fricke, Christine +4 more
core +1 more source
Antimicrobial Effect of Oxazolidinones and Its Synergistic Effect with Bedaquiline Against Mycobacterium abscessus Complex. [PDF]
Infect Drug Resist, 2023 Gao T +9 more
europepmc +1 more source
Bedaquiline: a new weapon against MDR and XDR-TB [PDF]
, 2017 Multidrug-resistant tuberculosis (MDR-TB) is a global public health problem. It requires treatment with combination therapy consisting of four to six drugs including combinations of bactericidal and bacteriostatic drugs, usually for a period of 2 years ...
Garewal, Nipunjot +3 more
core +1 more source
Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus. [PDF]
Microbiol Spectr, 2023 Negatu DA, Aragaw WW, Dartois V, Dick T.
europepmc +1 more source
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model. [PDF]
Antimicrob Agents Chemother, 2023 Li SY +7 more
europepmc +1 more source
Improved Radiosynthesis of [<sup>18</sup>F]-Labeled Oxazolidinone Antibiotics for Future Clinical Translation. [PDF]
ACS Infect DisSarhan M +9 more
europepmc +1 more source
In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates. [PDF]
Antimicrob Agents Chemother, 2021 Kim DH, Kim SY, Koh WJ, Jhun BW.
europepmc +1 more source